AEGON Asset Management (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113M Sell
443,703
-81,028
-15% -$18.9M 1.2% 21
2026
Q1
$128M Sell
524,731
-60,861
-10% -$14.2M 1.7% 12
2025
Q4
$121M Sell
585,592
-61,679
-10% -$12.2M 1.44% 14
2025
Q3
$120M Buy
647,271
+65,526
+11% +$11.2M 1.42% 13
2025
Q2
$88.8M Sell
581,745
-33,092
-5% -$5.09M 1.14% 20
2025
Q1
$102M Sell
614,837
-25,864
-4% -$4.05M 1.49% 14
2024
Q4
$92.7M Sell
640,701
-9,854
-2% -$1.53M 1.22% 17
2024
Q3
$105M Sell
650,555
-12,224
-2% -$1.95M 1.44% 12
2024
Q2
$96.8M Buy
662,779
+259,758
+64% +$38.6M 1.36% 14
2024
Q1
$63.8M Buy
403,021
+5,947
+1% +$947K 0.96% 30
2023
Q4
$62.2M Buy
+397,074
New +$60.9M 0.99% 28
2023
Q2
$62.1M Buy
375,579
+70,869
+23% +$11.4M 1% 24
2023
Q1
$47.2M Hold
304,710
0.82% 38
2022
Q4
$53.8M Buy
304,710
+30,860
+11% +$5.33M 0.97% 33
2022
Q3
$44.8M Buy
273,850
+160,627
+142% +$27.2M 0.91% 38
2022
Q2
$20.1M Buy
113,223
+5,999
+6% +$1.07M 0.38% 71
2022
Q1
$19M Sell
107,224
-333,323
-76% -$56.7M 0.28% 89
2021
Q4
$75.4M Sell
440,547
-1,595
-0.4% -$261K 0.97% 27
2021
Q3
$71.4M Sell
442,142
-102
-0% -$17.4K 1.02% 26
2021
Q2
$72.9M Sell
442,244
-5,187
-1% -$859K 1.04% 24
2021
Q1
$73.5M Sell
447,431
-93,535
-17% -$15.1M 1.09% 26
2020
Q4
$85M Sell
540,966
-4,005
-0.7% -$591K 1.24% 20
2020
Q3
$81M Buy
544,971
+6,759
+1% +$1M 1.64% 16
2020
Q2
$75.5M Sell
538,212
-140,598
-21% -$20.5M 1.7% 14
2020
Q1
$88.9M Sell
678,810
-28,820
-4% -$4.09M 2.56% 7
2019
Q4
$103M Buy
707,630
+12,477
+2% +$1.69M 2.47% 8
2019
Q3
$90M Sell
695,153
-11,008
-2% -$1.45M 2.37% 11
2019
Q2
$98.2M Sell
706,161
-11,555
-2% -$1.6M 2.65% 9
2019
Q1
$100M Buy
717,716
+15,910
+2% +$2.13M 2.84% 6
2018
Q4
$90.6M Buy
701,806
+492,035
+235% +$68.6M 2.89% 6
2018
Q3
$29M Buy
209,771
+20,222
+11% +$2.69M 0.69% 52
2018
Q2
$23M Sell
189,549
-247,069
-57% -$30.8M 0.57% 57
2018
Q1
$55.9M Sell
436,618
-251,303
-37% -$34M 1.43% 25
2017
Q4
$96.2M Sell
687,921
-17,290
-2% -$2.41M 2.43% 8
2017
Q3
$91.7M Buy
705,211
+1,247
+0.2% +$165K 2.51% 11
2017
Q2
$93.1M Sell
703,964
-11,933
-2% -$1.52M 2.62% 9
2017
Q1
$89.1M Sell
715,897
-30,491
-4% -$3.64M 2.39% 11
2016
Q4
$86M Sell
746,388
-276,660
-27% -$32M 2.43% 9
2016
Q3
$121M Sell
1,023,048
-731
-0.1% -$88.7K 3.39% 4
2016
Q2
$124M Buy
1,023,779
+14,212
+1% +$1.61M 3.55% 3
2016
Q1
$109M Buy
1,009,567
+5,078
+0.5% +$526K 3.29% 5
2015
Q4
$103M Buy
1,004,489
+297,367
+42% +$29.9M 3.01% 8
2015
Q3
$66M Sell
707,122
-36,888
-5% -$3.57M 2% 16
2015
Q2
$72.5M Buy
744,010
+91,986
+14% +$9.21M 2.01% 15
2015
Q1
$65.6M Buy
652,024
+277,408
+74% +$28.2M 1.72% 20
2014
Q4
$39.2M Sell
374,616
-29,772
-7% -$3.14M 4.32% 5
2014
Q3
$43.1M Sell
404,388
-1,621
-0.4% -$168K 4.89% 4
2014
Q2
$42.5M Buy
406,009
+9,405
+2% +$951K 4.88% 5
2014
Q1
$39M Buy
396,604
+11,412
+3% +$1.06M 4.48% 6
2013
Q4
$35.3M Buy
385,192
+18,135
+5% +$1.67M 5.04% 4
2013
Q3
$31.8M Sell
367,057
-4,333
-1% -$389K 7.02% 4
2013
Q2
$31.9M Buy
+371,390
New +$31.5M 7.47% 4

Other funds holding JNJ

AEGON Asset Management (UK)'s JNJ Position: Q2 2026 in Review

AEGON Asset Management (UK) reduced its Johnson & Johnson (JNJ) stake by 15% in Q2 2026, selling an estimated $18.9M and leaving 443,703 shares worth $113M. The position accounts for 1.2% of the portfolio, ranked #21.

AEGON Asset Management (UK) first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $128M in Q1 2026. 2,122 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AEGON Asset Management (UK) held 443,703 shares of Johnson & Johnson worth $113M as of Q2 2026.
  • AEGON Asset Management (UK) sold 81,028 Johnson & Johnson shares in Q2 2026, an estimated $18.9M.
  • Johnson & Johnson made up 1.2% of AEGON Asset Management (UK)'s portfolio in Q2 2026, its #21 holding.
  • AEGON Asset Management (UK) first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • AEGON Asset Management (UK)'s Johnson & Johnson position peaked at $128M in Q1 2026.
  • 2,122 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2026, filed 13 Jul 2026.